Drug intelligence / Profile preview

immunoglobulin Y (anti-Helicobacter pylori)

Development stage
Preclinical
Lead developer
IgY-research
Modality
Antibody-Based Therapeutics
Administration
Oral
01

Overview

**Immunoglobulin Y anti-Helicobacter pylori** refers to an IgY-research program comprising orally administered, chicken egg-yolk-derived polyclonal IgY antibodies directed against *Helicobacter pylori*. The antibodies are generated by immunizing hens with *H. pylori* antigens and harvesting antigen-specific IgY from egg yolk. The intended mechanism is local neutralization of *H. pylori* in the gastrointestinal tract, including interference with bacterial virulence functions such as urease activity, thereby reducing colonization and infection burden. IgY-research has publicly described anti-*H. pylori* IgY work in human-health research materials, including dietary and functional-food studies; however, a distinct standardized pharmaceutical product, development code, formulation, and formal clinical phase are not publicly established. ([igy-research.com](https://igy-research.com/effect-of-dietary-anti-helicobacter-pylori-urease-immunoglobuline-y-on-helicobacter-pylori-infection/))

Other names
anti-Helicobacter pylori IgYanti-H. pylori IgY
02

Targets

H. pylori (Helicobacter pylori)UreB (Urease subunit beta)Flagellin

Beyond the preview

Go deeper on immunoglobulin Y (anti-Helicobacter pylori).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on immunoglobulin Y (anti-Helicobacter pylori).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call